The Pharmaceutical Industry Chamber at the Federation of Egyptian Industries welcomed a delegation from the Egyptian Society of Cardiology, headed by Professor Dr. Mohamed Abdel-Ghani, President of the Society. The delegation included Professor Dr. Mostafa Moqarrab, Professor Dr. Haitham Soliman Gharib, and Professor Dr. Mohamed Zahran, members of the Society’s Board of Directors. The meeting took place at the headquarters of the Federation of Egyptian Industries.
The delegation was received by Dr. Gamal El-Leithy, Chairman of the Pharmaceutical Industry Chamber, in the presence of several members of the Chamber’s Board of Directors. The meeting reflected both parties’ commitment to strengthening cooperation between the industrial sector and scientific and medical institutions in support of Egypt’s healthcare system.
The meeting addressed several topics of mutual interest, foremost among them strengthening the partnership between the pharmaceutical industry and scientific research, as well as supporting applied studies and research that contribute to advancing healthcare and meeting the needs of Egyptian society. These efforts aim to maximize the use of Egypt’s national scientific and industrial capabilities.
Both parties also emphasized the importance of supporting the Egyptian pharmaceutical industry as a cornerstone of national drug security. They highlighted the need to provide high-quality Egyptian pharmaceutical products at affordable prices, ensuring the sustainable availability of medicines and easing the financial burden on patients, particularly those with limited incomes.
The two parties agreed on the importance of maintaining ongoing coordination and cooperation between the Pharmaceutical Industry Chamber and the Egyptian Society of Cardiology to launch joint initiatives and programs that support scientific research, advance medical practice, and strengthen the position of Egyptian medicines in local and regional markets. These efforts ultimately aim to serve the interests of Egyptian patients and support the continued development of sustainable healthcare.